Cite
HARVARD Citation
An, Y. et al. (n.d.). AB0514 Efficacy and Safety of Tofacitinib in Chinese Patients with Active Rheumatoid Arthritis: Subgroup Analysis from a Phase 3 Study of Tofacitinib in Combination with Nonbiologic Disease-Modifying Antirheumatic Drugs. Annals of the rheumatic diseases. p. 1071. [Online].